D'Onofrio, Gail and Edelman, E Jennifer and Hawk, Kathryn F and Chawarski, Marek C and Pantalon, Michael V and Owens, Patricia H and Martel, Shara H and Rothman, Richard and Saheed, Mustapha and Schwartz, Robert P and Cowan, Ethan and Richardson, Lynne and Salsitz, Edwin and Lyons, Michael S and Freiermuth, Caroline and Wilder, Christine and Whiteside, Lauren and Tsui, Judith I and Klein, Jared W and Coupet, Edouard and O'Connor, Patrick G and Matthews, Abigail G and Murphy, Sean M and Huntley, Kristen and Fiellin, David A (2023) Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder. JAMA Network Open, 6, (4), e235439. 10.1001/jamanetworkopen.2023.5439.
External website: https://jamanetwork.com/journals/jamanetworkopen/f...
Importance: Emergency department (ED)-initiated buprenorphine for the treatment of opioid use disorder (OUD) is underused.
Question: Does implementation facilitation (IF) increase adoption of emergency department (ED)–initiated buprenorphine and patient engagement in opioid use disorder treatment compared with grand rounds?
Findings: In this nonrandomized hybrid type 3 effectiveness implementation trial conducted in 4 urban, academic EDs comparing 394 patients enrolled during a baseline evaluation period after grand rounds and 362 patients enrolled during an IF evaluation period, rates of ED-initiated buprenorphine and engagement in OUD treatment at 30 days were higher during the IF period.
Meaning: These findings suggest that IF was associated with greater rates of ED-initiated buprenorphine and patient engagement in treatment at 30 days compared with grand rounds.
B Substances > Opioids (opiates) > Opioid product > Buprenorphine / Suboxone
HJ Treatment or recovery method > Substance disorder treatment method > Substance disorder drug therapy (pharmacological treatment)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
J Health care, prevention, harm reduction and treatment > Type of care > Emergency care
J Health care, prevention, harm reduction and treatment > Health care delivery
J Health care, prevention, harm reduction and treatment > Health care programme, service or facility > Hospital
VA Geographic area > United States
Repository Staff Only: item control page